Early living donor liver transplantation for alcohol-associated hepatitis

Simple item page
dc.contributor.authorKulkarni, Anand V.
dc.contributor.authorReddy, Raghuram
dc.contributor.authorArab, Juan Pablo
dc.contributor.authorSharma, Mithun
dc.contributor.authorShaik, Sameer
dc.contributor.authorIyengar, Sowmya
dc.contributor.authorKumar, Naveen
dc.contributor.authorGupta, Rajesh
dc.contributor.authorPremkumar, Giri Vishwanathan
dc.contributor.authorMenon, Balachandran Palat
dc.contributor.authorReddy, Duvvur Nageshwar
dc.contributor.authorRao, Padaki Nagaraja
dc.contributor.authorReddy, K. Rajender
dc.date.accessioned2025-01-20T20:10:57Z
dc.date.available2025-01-20T20:10:57Z
dc.date.issued2023
dc.description.abstractIntroduction and Objectives: Lately, there has been a steady increase in early liver transplantation for alcohol -associated hepatitis (AAH). Although several studies have reported favorable outcomes with cadaveric early liver transplantation, the experiences with early living donor liver transplantation (eLDLT) are limited. The primary objective was to assess one-year survival in patients with AAH who underwent eLDLT. The second-ary objectives were to describe the donor characteristics, assess the complications following eLDLT, and the rate of alcohol relapse.Materials and Methods: This single-center retrospective study was conducted at AIG Hospitals, Hyderabad, India, between April 1, 2020, and December 31, 2021.Results: Twenty-five patients underwent eLDLT. The mean time from abstinence to eLDLT was 92.4 +/- 42.94 days. The mean model for end-stage liver disease and discriminant function score at eLDLT were 28.16 +/- 2.89 and 104 +/- 34.56, respectively. The mean graft-to-recipient weight ratio was 0.85 +/- 0.12. Survival was 72% (95%CI, 50.61-88) after a median follow-up of 551 (23-932) days post-LT. Of the 18 women donors,11 were the wives of the recipient. Six of the nine infected recipients died: three of fungal sepsis, two of bacterial sepsis, and one of COVID-19. One patient developed hepatic artery thrombosis and died of early graft dysfunction. Twenty percent had alcohol relapse.Conclusions: eLDLT is a reasonable treatment option for patients with AAH, with a survival of 72% in our expe-rience. Infections early on post-LT accounted for mortality, and thus a high index of suspicion of infections and vigorous surveillance, in a condition prone to infections, are needed to improve outcomes.(c) 2023 Fundacion Clinica Medica Sur, A.C. Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/)
dc.fuente.origenWOS
dc.identifier.doi10.1016/j.aohep.2023.101098
dc.identifier.issn1665-2681
dc.identifier.urihttps://doi.org/10.1016/j.aohep.2023.101098
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/92109
dc.identifier.wosidWOS:001002387800001
dc.issue.numero4
dc.language.isoen
dc.revistaAnnals of hepatology
dc.rightsacceso restringido
dc.subjectGender bias
dc.subjectIndia
dc.subjectAlcohol relapse
dc.subject.ods03 Good Health and Well-being
dc.subject.odspa03 Salud y bienestar
dc.titleEarly living donor liver transplantation for alcohol-associated hepatitis
dc.typeartículo
dc.volumen28
sipa.indexWOS
sipa.trazabilidadWOS;2025-01-12
Files
Collections
Artículos de revistas